Use of urinary naloxone levels in a single provider practice: a case study

BACKGROUND: Urine drug monitoring for medications for opioid use disorder (MOUD) such as buprenorphine can help to support treatment adherence. The practice of introducing unconsumed medication directly into urine (known as “spiking” samples) has been increasingly recognized as a potential means to...

Descripción completa

Detalles Bibliográficos
Autores principales: Warrington, Jill S., Booth, Kaitlyn, Warrington, Gregory S., Francis-Fath, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964102/
https://www.ncbi.nlm.nih.gov/pubmed/31941557
http://dx.doi.org/10.1186/s13722-020-0178-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964102/
https://www.ncbi.nlm.nih.gov/pubmed/31941557
http://dx.doi.org/10.1186/s13722-020-0178-9

Ejemplares similares